• American Cancer Society Clinical Research Professor

• 25 years leading translational research programs in academic medicine at premier cancer centers in the U.S.

• Over 35+ inventions filed in U.S. and Ex-U.S. territories

• 8 drugs approved across 50 countries

• Experience as Chief Scientific Officer overseeing approvals of drugs in B-cell lymphoma, autoimmune D/O & pipeline development

​​

• Over 25 years in operations, finance, investment banking, oncology drug development, investor relations and corporate communications

• Experience in academic clinical trial monitoring and data analysis in oncology

• Responsible for operations for a turnaround oncology company

• Built advisory firm for public and private biotechnology companies to advise and manage investor relations, corporate communications and business development

• Director of the University of Virginia Comprehensive Cancer Center, an NCI Designated Cancer Center

• F. Palmer Weber-Smithfield Foods Professor of Oncology Research

• Discovered LGL leukemia

• Worked in laboratory of the Noble Laureate E. D. Thomas

• Continuous federal funding for his laboratory over the past 36 years totaling over $115M over his career 

• President & CEO, Leavorac Group

• Former CEO of MundiPharma EDO

• More than 20 years in all phases oncology drug developmen

• Focused on the treatment and development of therapeutics in cardiology, haematology/oncology and paediatric oncology

• Board certified pharmacologist